SOURCE: Equity News Circuit

Equity News Circuit

May 29, 2013 08:45 ET

Free Research Reports on AMRN, CVI, SVA and WTSL Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwired - May 29, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Amarin Corporation plc (NASDAQ: AMRN) shares declined 5.75 percent on volume of 11.66 million shares traded to close at $6.39. On Tuesday, rival drug maker, AstraZeneca plc, purchased Omthera Pharmaceuticals Inc. for approximately $260 million. Omthera is currently developing a fish oil-based treatment that could potentially compete with Amarin's Vascepa.

Find out more about Amarin including full access to the free equity report at: www.BedfordReport.com/AMRN

CVR Energy, Inc. (NYSE: CVI) shares spiked over 3.0 percent on volume of 1.5 million shares traded Tuesday. The company's Board of Directors has declared a special dividend of $6.50 per share payable on June 10, 2013, to stockholders of record at the close of business on June 3, 2013. Shares of CVR Energy have gained approximately 44 percent year-to-date.

Find out more about CVR Energy including full access to the free equity report at: www.BedfordReport.com/CVI

Sinovac Biotech Ltd. (NASDAQ: SVA) shares soared 20.5 percent on volume of 1.19 million shares traded to close at $3.99. The company reported sales of their hepatitis A vaccine Healive totaled $6.2 million for the first quarter of 2013, compared to $1.6 million in the year ago quarter. Shares of Sinovac are up approximately 27 percent year-to-date.

Find out more about Sinovac Biotech including full access to the free equity report at: www.BedfordReport.com/SVA

The Wet Seal, Inc. (NASDAQ: WTSL) shares traded in the range of $4.45 to $4.59 Tuesday before settling to close at $4.50 a share. The company reported a net income of $3.1 million, or $0.03 per diluted share, for the first quarter of fiscal 2013, compared to a net loss of $0.3 million in the year ago quarter.

Find out more about The Wet Seal including full access to the free equity report at: www.BedfordReport.com/WTSL

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information